Galactomannan (GM) is an essential molecule in the life of the human opportunistic fungal pathogen Aspergillus fumigatus. It is a polysaccharide that is an important structural component of the cell wall of A. fumigatus (10) . GM is secreted during growth in culture (15) and has also been shown to exist in a glycosylphosphatidylinositol membrane-bound form (C. Costachel et al., unpublished data). The extracellular, membrane-or cell wall-linked GMs have a similar chemical organization composed of a linear ␣-mannan core with a repeating tetramannose unit (2M-6M-2M-2M) with side chains of ␤-1,5-galactofuranosyl residues with an average degree of polymerization of 4 attached to the ␣-1,2-linked mannose residues of the mannan chain (10, 15) . GM is also produced in the host and is a well-known A. fumigatus antigen. Antibodies directed against this polysaccharide have been detected in patients with aspergilloma and in experimentally infected animals or in rabbits or mice hyperimmunized with total extracts of A. fumigatus (15, 26) . In addition, it has been repeatedly shown that this molecule circulates in the biological fluids of patients with invasive aspergillosis. Indeed, serological diagnosis of this lifethreatening fungal infection remains based on the detection of GM in the serum, urine, or bronchoalveolar lavage samples of infected patients (18, 29, 31 ) since heavily immunocompromised patients at risk for invasive aspergillosis are not able to mount an antibody response against A. fumigatus. MAbs or polyclonal antibodies directed against GM have been used in the search for circulating antigens. The only commercial kit available for detection of GM is a sandwich enzyme-linked immunosorbent assay (ELISA) based on the use of a rat monoclonal antibody (MAb), EB-A2, that reacts specifically with the galactofuranose (Galf)-containing moiety of the GM. In vitro, the best inhibition was obtained with a tetra-␤-1,5-galactofuranosoligosaccharide, suggesting that this oligosaccharide was the epitope recognized by the MAb (30) .
Glycoproteins reacting positively with anti-galactofuran MAb EB-A2 have been identified in culture filtrates or mycelial extracts by Western blotting experiments (11, 30) . These results suggested that A. fumigatus can secrete both a polysaccharide GM and glycoproteins bearing a galactofuran moiety. Recently, an ␣-galactosidase with a Galf-rich N-glycan was identified in Aspergillus niger. Analysis of the N-glycan moiety of the ␣-galactosidase showed that it was composed of a mixture of Hex [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] HexNAc 2 substituted with up to three ␤-Galf residues (36) .
In this work, we have isolated and characterized two major galactomannoproteins (GMPs) secreted by A. fumigatus in a glucose-peptone-based medium. Biochemical and molecular analyses have shown that these GMPs were a phospholipase C (PLC) and a phytase. The chemical structure of the N-glycan has been characterized and shown to contain Galf in a terminal nonreducing position.
MATERIALS AND METHODS
Strains and standard culture conditions. A. fumigatus strain CBS 144-89 was grown in Sabouraud's liquid medium (2% glucose, 1% mycopeptone; Biokar, Beauvais, France). Cultures were performed in a 15-liter fermentor in Sabouraud's liquid medium for 24 h at 25°C as previously described (15) . Paracoccidioides brasiliensis strain B339 was grown in YPD at 37°C as previously described (2) .
Preparation of protein extracts and protein purification. A culture filtrate from a 15-liter fermentor was precipitated using 4 volumes of 100% ethanol overnight at 4°C. After centrifugation (5,000 ϫ g, 10 min), the precipitate was resuspended in 100 ml of 50 mM ammonium acetate, ultrasonicated, and centrifuged and the supernatant was dialyzed against a 10 mM sodium acetate buffer (pH 6.2). Sample was loaded onto a Mono S HR 5/5 column (Pharmacia, Uppsala, Sweden) and eluted with a linear NaCl gradient (0 to 500 mM in 45 min) at a flow rate of 0.8 ml/min. Fractions were tested by Western blot assays with the Bio-Rad anti-GM EB-A2 MAb. Positive fractions were further purified by gel filtration chromatography on a Superdex 75 HR 10/30 column (Pharmacia) in the same acetate buffer supplemented with 120 mM NaCl at a flow rate of 0.4 ml/min. The last purification step was performed on the same Mono S HR 5/5 cation-exchange chromatography column equilibrated with acetate buffer (10 mM at pH 5.7). After dialysis against this buffer, positive anti-GM fractions obtained from the gel filtration column were loaded onto the column and eluted with a linear gradient of NaCl (100 to 250 mM in 30 min) at a flow rate of 0.5 ml/min. Purified proteins were kept at 4°C in the elution buffer.
To obtain the gp43 antigen, culture supernatants from a 5-day-old culture of P. brasiliensis were inactivated with 0.02% thimerosal for 2 h at 35°C and precipitated with 4 volumes of 100% ethanol. The precipitate was resuspended in 10 mM sodium acetate buffer (pH 5.0) and dialyzed against the same buffer.
Protein analysis. Protein samples were analyzed by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) (14) using 4% stacking and 10% separating gels. Proteins were stained with Coomassie blue or electrotransferred to nitrocellulose overnight at 30 V in 50 mM Tris HCl (pH 8.0) buffer containing 200 mM glycine and 20% ethanol. Blots were immunolabeled with anti-GM MAb EB-A2 (30) . The MAb was used at a 1:10,000 dilution (0.27 g immunoglobulin M [IgM]/ml). Immunolabeling used a peroxidase anti-rat IgG (heavy and light chains) conjugate diluted 1:1,000 and the ECL detection method of Amersham. Internal peptide sequencing was performed by J. D'Alayer (Plateau Technique d'Analyse et de Microséquençage des Protéines, Institut Pasteur) on an Applied Biosystems 470 apparatus as described earlier (4). To de-N-glycosylate the protein, 100 g of the protein in 100 l of 20 mM of NH 4 HCO 3 with 2.5 l of a mixture of 10% SDS and 10% mercaptoethanol was boiled for 10 min. After cooling, 100 l of 20 mM NH 4 HCO 3 , 10 l of NP-40 (10%), and 2 l of peptide:N-glycanase (PNGase) F (10 U) were added and the mixture was incubated overnight at 37°C. Molecular shifts associated with Ndeglycosylation were followed by SDS-PAGE after Coomassie blue staining of the protein.
Sequence analysis. Peptide sequences were used to screen the genome sequence published in The Institute for Genomic Research (TIGR) database (http://tigrblast.tigr.org//usr/local/db/euk/private/aspergillus/annotation_dbs/ASP .pep) (17 October 2003) . The position of the introns in the database was confirmed after amplification of cDNA by PCR using primers flanking the putative intron identified after analysis of the genomic sequence. For example, in GMP1 a unique intron was identified and the primers employed to verify the presence of the intron were 5Ј-GGCTTCGTTCATGAGCAG-3Ј and 5Ј-GCTGGAAGA TGGACCGCT-3Ј.
Analysis of PLC and phytase activities. Demonstration of the PLC activity was performed using 14 C-radiolabeled phosphatidylcholine (PC) following a modification of the method of Johansen et al. (12) . Five micrograms of enzyme was mixed in 100 l of 125 mM Tris buffer (pH 6.0) containing 0.1% deoxycholate with 10 g of PC containing 0.045 Ci 14 C-labeled PC (L-3-PC, 1,2-di[1-14 C]palmitoyl; Amersham). The reaction mixture was sonicated for 1 min in a bath sonicator and incubated overnight at 37°C. A 10-l sample of the reaction mixture was applied to a thin-layer chromatography (TLC) plate (Silica Gel 60 F 254 ; Merck). Plates were eluted with petroleum ether-ethyl ether-acetic acid (50/50/1, vol/vol/vol). TLC plates were analyzed with a Typhoon phosphorimager (Molecular Dynamics). To quantify the PLC activity, a colorimetric assay was carried out using a modified version of the protocol of Kurioka and Matsuda (13) . p-Nitrophenyl PC (NPCC) was employed as the substrate at 2.5 mM incubated with 10 g of protein in 100 mM sodium acetate buffer (pH 5.0). The reaction mixture was incubated for 10 min at 37°C, and the assay was stopped with 1 ml of 6% Na 2 CO 3 . The optical density (OD) was measured at 410 nm. For K m determination, concentrations of 2.5 to 100 mM NPCC were used. Quantification of the lysis of different PLC substrates was done basically as described by Preuss et al. (22) . Briefly, mixtures of unlabeled (5 g) and radiolabeled (0.02 Ci) substrates in 2 l were added to 150 l of a 150 mM Tris HCl buffer (pH 6.2) containing 5 g protein and 0.1% sodium deoxycholate. The radioactive substrates tested and their corresponding unlabeled substrates were L-3-
, and L-3-phosphatidyl [2- 3 H]inositol (PI; Amersham). After a 1-h incubation at 37°C, 500 l of a chloroform-butanol-concentrated hydrochloric acid (10/10/6) solution and 750 l distilled water were added to the 150-l reaction mixture. After vortexing, two phases were obtained. The radioactivity present in the upper aqueous phase containing the digested lipid and the lower chloroformic phase containing the undigested phospholipid was quantified.
Phytase activity was determined as previously described (21) using phytic acid (Sigma) as the substrate at 5 mM in 100 mM sodium acetate buffer (pH 5.0). The reaction mixture was incubated at 37°C. The phosphate released was quantified by the method of Ames (3) .
Glycan isolation. Purified GMP was dialyzed against 50 mM ammonium hydrogen carbonate at 4°C for 48 h. After lyophilization, the protein sample was dissolved in 1 ml of 600 mM Tris-HCl (pH 8.5) and reduced with 100 g dithiothreitol (DTT)/mg protein (fourfold molar excess of DTT over the number of S-S bridges). The sample was flushed with argon and incubated at 37°C for 2 h. After addition of 500 g of iodoacetic acid per mg protein (5 M excess over DTT), the sample was flushed again with argon and incubated at room temperature overnight in darkness. The sample was then dialyzed for 48 h against 50 mM ammonium hydrogen carbonate at 4°C and lyophilized. The reduced carboxymethylated protein was digested with L-1-tosylamide-2-phenylethylchloromethylketone bovine pancreas trypsin (EC 3.4.21.4; Sigma) with an enzyme-tosubstrate ratio of 1:50 (by mass), and the mixture was incubated for 5 h at 37°C in 50 mM ammonium bicarbonate buffer (pH 8.4). The reaction was terminated by boiling for 5 min before lyophilization.
An aliquot of the tryptic digest of the reduced-carboxymethylated protein was injected onto a Sep-Pak C 18 cartridge (Waters Ltd.) and the aqueous eluent tested for reactivity with EB-A2. It was verified for each protein tested that this aqueous C 18 Sep-Pak eluate always gave a negative reaction with the ELISA since a positive reaction would indicate a noncovalent binding of galactofuran molecules that would have contaminated the protein during the extraction and purification procedures.
After running this control, PNGase F (EC 3.2.2.18; Roche Molecular Biochemicals) digestion was carried out in ammonium bicarbonate buffer (50 mM, pH 8.4) for 16 h at 37°C using 6 U of the enzyme per mg of tryptic digest. The reaction was terminated by lyophilization, and the products were purified on a C 18 Sep-Pak cartridge to separate the N-glycans from the peptides. After conditioning the C 18 Sep-Pak cartridge by sequential washing with methanol (5 ml), 1-propanol (5 ml), and 5% acetic acid (2 ϫ 5 ml), the sample was loaded onto the Sep-Pak cartridge and eluted stepwise with 3 ml of 5% acetic acid, 2 ml of 20% 1-propanol, 2 ml of 40% 1-propanol, 2 ml of 60% 1-propanol, and finally 2 ml of 1-propanol.
Sep-Pak-purified N-glycans were digested with 0.5 U ␣-mannosidase (from jack bean; EC 3.2.1.24; Roche Molecular Biochemicals) in 200 l of 50 mM ammonium acetate buffer (pH 4.5) for 48 h at 37°C. The reaction was terminated by boiling for 5 min before lyophilization. Since McConville et al. (20) have shown that hydrofluoric acid (HF) treatment only hydrolyzed glycosidic bonds involving residues in the furanose configuration and left the other linkages unbroken, N-glycans were also treated with 100 l of 48% HF (Aldrich) at 0°C for 48 h. HF was removed under a stream of nitrogen for 1 h (28). Mannosidaseand HF-treated N-glycans were purified on a Sep-Pak cartridge as described above and permethylated for matrix-assisted laser desorption (MALD)-mass spectrometry (MS) and gas chromatography (GC)-MS analysis. When permethylated, N-glycans were eluted from the Sep-Pak cartridge with 50% acetonitrile.
Reactivity of N-glycans to anti-galactomannan MAb. To verify the presence or absence of Galf residues in the different fractions containing N-glycans, a commercial sandwich ELISA developed for the detection of GM in blood samples was used (Platelia Aspergillus; Bio-Rad) (29) . The untreated galactomannoprotein at a concentration of 10 to 50 ng was employed as a positive control. Equivalent amounts of N-glycans after different treatments were used. For each sample, 1/10 and 1/100 dilutions were tested. ELISA was performed as recommended by the manufacturer, except that the samples to be analyzed were used without boiling in the extraction buffer.
Carbohydrate composition of N-glycan. Monosaccharides from Sep-Pak-purified N-glycans were analyzed by gas-liquid chromatography as alditol acetates obtained after hydrolysis (4 N trifluoroacetic acid, 100°C, 4 h), reduction, and peracetylation (27) . Derivatized monosaccharides were separated and quantified on a DB5 capillary column (25 m by 0.32 mm; SGE) using a Delsi 200 apparatus (carrier gas, 0.7 bar helium; temperature program, 120 to 180°C at 2°C/min and 180 to 240°C at 4°C/min).
MALD-MS and GC-MS analyses of N-glycans. Permethylation using the sodium hydroxide procedure was performed according to Ciucanu and Kerek (7) . After derivatization, the reaction products were purified on a C 18 Sep-Pak cartridge according to Dell et al. (9) . Partially methylated alditol acetates were prepared from permethylated samples for GC-MS linkage analysis as described previously (1). Gas-liquid chromatography-MS analyses were recorded using an Automass II 30 quadrupolar mass spectrometer interfaced with a Carlo Erba 8000 Top gas chromatograph (Finnigan, Argenteuil, France). Electron ionization spectra were recorded using an ionization energy of 70 eV. The gas chromatograph was equipped with a CP-Sil 5CB/MS capillary column (25m by 0.32 mm; Chrompak), and helium was supplied at a flow rate of 2 ml/min. The partially methylated alditol acetates were dissolved in methanol prior to on-column in-VOL. 4 Antigenicity testing. Native or de-N-glycosylated GMPs were blotted onto nitrocellulose as described above. After blocking, blots were incubated with a pool of 17 sera from different aspergilloma patients and a pool of 7 control sera (kind gift of P. Recco, Toulouse, France). Human sera were diluted 1/1,000 and labeled with an anti-human peroxidase conjugate diluted 1/1,000. Peroxidase binding was verified with ECL chemiluminescence (Amersham) as described by the manufacturer. Quantification of the humoral response was done in an ELISA format. GMP1, GMP2, and GM (15) were coated onto ELISA plates (Greiner reference no. 762070) at a concentration of 2 g/ml in 0.1 M carbonate buffer (pH 9.0). After coating, the wells were washed with phosphate-buffered saline (PBS)-0.1% Tween 20. Patient sera were diluted 1/500 in PBS containing 0.05% Tween 20 and 1% bovine serum albumin. The ELISA contained classically the following steps: incubation for 1 h at 37°C with 24 individual control and patient sera; five washings with PBS-0.05% Tween 20; incubation with a secondary anti-IgG (heavy and light chains) antibody conjugated to peroxidase (Sigma); and five washings and incubation with O-phenylenediamine dihydrochloride (OPD) for OD readings. Experiments were done in duplicate and repeated at least once. Statistical analysis of the data was done using the JMP software (SAS, Cary, NC). Variance analysis was used for mean comparisons and for bivariate analysis of the distribution of one continuous variable to another one.
RESULTS

Identification of GMPs.
The two major proteins secreted in the culture filtrate (GMP1 and -2) that reacted with the antigalactofuran antibody were purified. These proteins bound to the cation-exchange Mono S column. GMP1 was eluted at 140 to 180 mM NaCl at pH 6.2. The GMP1-containing fractions were collected, pooled, and further purified by gel filtration. On Superdex 75, GMP1 was found in fractions of 55 to 60 kDa. These fractions were pooled, dialyzed, and subjected to a second cation-exchange chromatography at pH 5.7. GMP1 was eluted at 150 to 160 mM NaCl. GMP2 was eluted initially from the cation-exchange Mono S column with a 320 to 340 mM NaCl solution at pH 6.2. A further purification step with the fractions containing GMP2 was realized on a Superdex 75 gel filtration column. GMP2 was recovered in the 55-to 65-kDacontaining fractions. Figure 1 shows the apparent M r of the native and N-deglycosylated GMPs. The molecular mass shift resulting from Ndeglycosylation was between 10 and 15 kDa, indicating the presence of small N-glycans. N-deglycosylation was always associated with the loss of the reactivity with the anti-GM MAb.
Structural characterization of N-glycan of GMP1. (i) Native glycans released by PNGase F. GC analysis showed that the mixture of PNGase F-released oligosaccharides contained mannose, galactose, and N-acetylglucosamine in a molar ratio of 6.4:2.3:2.
Data from MALD-MS of permethylated PNGase F-released glycans eluting in the 50% (vol/vol) aqueous acetonitrile fraction from a C 18 Sep-Pak cartridge are shown in Fig. 2A . The data indicated that the glycoprotein contained glycans with a GC-MS analysis of partially methylated alditol acetates generated from the permethylated glycans is shown in Table 1 . Key features of these data are as follows. (i) 3,6-Man, 2,6-Man, 2-Man, 6-Man, and 4-GlcNAc are components of the N-glycan core; (ii) Man and Gal are the nonreducing sugars; (iii) the fragmentation pattern of terminal Gal is consistent with a terminally linked hexofuranose sugar; and (iv) no 4-Gal was detected, suggesting that no chains of galactofuran are present in the N-glycan.
HF treatment and ␣-mannosidase digestion of N-glycans released by PNGase F. GC-MS data showed that a 48-h treatment at 0°C with 48% HF removed all terminal Galf residues from the N-glycans. In addition, HF-treated N-glycans did not react with the anti-galactofuran MAb, even though a concentration of HF-treated N-glycans 100 times higher than untreated N-glycans was tested by ELISA (data not shown). The MALD-MS spectrum of permethylated HF-treated N-glycans eluting in the 50% (vol/vol) aqueous acetonitrile fraction from a C 18 Sep-Pak cartridge is shown in Fig. 2 . The overall MALD-MS pattern of the HF-treated glycan could be roughly superimposed on the native glycan if one hexose unit is removed (compare Fig. 2A and B) . After HF treatment removing Galf residues, the oligosaccharides had an average size of 6.2 hexose units (calculated as follows: number of hexose units of each oligosaccharide species ϫ % of each oligosaccharide species/100), whereas the native oligosaccharide showed an average size of 7.1 hexose units. These data suggested the presence of one galactofuranosyl unit per average oligosaccharide. However, the molecular ion at m/z 1,783 (Hex 6 HexNAc 2 ) was present in a higher concentration than the Hex 7 HexNAc 2 before HF treatment, suggesting that another isomeric struc- 
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ture of Hex 6 HexNAc 2 without Galf residues was also present in the original native mixture of N-glycans. GC-MS data showed that after HF treatment, 2-linked Man was the only linked mannose residue which decreased significantly ( Table 1 ), suggesting that terminal Galf residues were attached to the 2 position of Man prior to HF treatment. This result was in agreement with Western blot data showing the absence of reactivity of a culture filtrate of P. brasiliensis with EB-A2 (data not shown). This extract contained the major glycoprotein gp43 that was characterized by the presence of ␤-D-Galf linked in ␤-1,6 to one of the mannosyl residues of the N-glycan mannan core (2) .
When native glycan pools were subjected to ␣-mannosidase digestion prior to HF treatment, the reactivity of the resulting N-glycans digested with ␣-mannosidase against the anti-GM MAb was identical to the reactivity of the native N-glycans, indicating that this exomannosidase treatment did not remove any Galf residues (data not shown). When the HF-treated N-glycans were digested with ␣-mannosidase, they were trimmed to HexHexNAc 2 (m/z 763), Hex 2 HexNAc 2 (m/z 967), and Hex 3 HexNAc 2 (m/z 1,171).
The chemical and immunochemical data obtained above showed that GMP1 of A. fumigatus contained a heterogeneous mixture of N-glycans (Hex 5-13 HexNAc 2 ). The N-glycans reacting with the anti-GM MAb contained only one Galf residue at the terminal nonreducing position attached to the 2 position of the mannose residues.
Structural characterization of N-glycan of GMP2. N-glycans of GMP2 were released by PNGase treatment as described for GMP1. ELISAs showed that the mixture of native PNGasereleased oligosaccharides reacted positively with the anti-galactofuran EB-A2 MAb (data not shown). These experiments indicated the presence of Galf residues in the mixture of Nglycans. The MALD-MS data indicated that the glycoprotein contained glycans with a Hex 6-11 HexNAc 2 composition. The major native molecular ions observed corresponded to Hex 7 HexNAc 2 (m/z 1,581) and Hex 8 HexNAc 2 (m/z 1,743), indicating that GMP2 N-glycans were similar to GMP1 N-glycans in size (Fig. 3) . After HF treatment removing Galf residues, the oligosaccharides had an average size of 7.2 hexose units whereas the native oligosaccharides showed an average size of 8.0 hexose units. These data suggested the presence of one galactofuranosyl unit per average oligosaccharide. GC-MS data showed that the Galf was only present at the nonreducing end of the mannan chains since only terminal Galf units were seen and no internal Galf side chains were identified (data not shown). GC-MS data also confirmed the conclusions obtained with GMP1 since the 2-Man concentration diminished after HF treatment of the native oligosaccharides (data not shown). A stretch of hydrophobic amino acids was seen at the amino terminus, and a putative signal peptide at the NH 2 terminus was predicted by the program SignalP (http://www.cbs.dtu.dk/services/SignalP) and in agreement with the (Ϫ3 Ϫ1) rule of Von Heijne (35) . The putative cleavage site was between A18 and I19.
BLAST analysis of the deduced amino sequence of the A. fumigatus protein showed a high degree of similarity with bacterial PLCs (47% and 38% similarities with Mycobacterium tuberculosis and Pseudomonas aeruginosa PLCs) and a putative PLC from Arabidopsis thaliana (37% similarity). No homologies were seen with other fungal phospholipases present in the database, but BLAST against the TIGR A. fumigatus database, however, showed the presence of two other homologous sequences (clones 65.m07340 and 52.m03766 in the TIGR database).
TLC analysis showed that upon incubation of the purified GMP1 with 14 C-labeled PC, diacylglycerol was released, showing that GMP1 had PLC activity (Fig. 4) . The enzymatic capacity to degrade different PLC substrates (PC, PE, SM, and PI) was investigated. Under the experimental conditions tested, the most efficiently degraded substrate was SM. PE was not cleaved. At the same substrate concentration, the amounts of radioactivity released from PC and PI were, respectively, 71 and 31% of the amount released from SM. Using NPCC as a substrate, the enzyme had a K m value of 3.85 Ϯ 0.7 mM, with a specific activity for the batch analyzed of 30 Ϯ 8 pmol/min/ g.
(ii) GMP2. An internal peptide sequence (KALARSVVPF IRASGS) obtained from the 70-kDa GMP2 protein matched PhyAp, a secreted phytase from A. fumigatus (16, 21, 24, 34) . The mature PHYA-encoded enzyme consisted of 439 amino acids with a theoretical M r of 48,270 (GenBank accession no. U59804 [58.m07761 in the TIGR database]). The protein possessed seven putative N-glycosylation sites. It had high homologies with other phytases or acid phosphatases: 66%, 61%, and 48% identity to phytases of A. niger, A. terreus, and Myceliophthora thermophila, respectively (21). In the genome of A. fumigatus, it belong to a cluster of three phytase genes, including the ORFs 52.m04104 and 66.m04644, and it also had homologies with two acid phosphatase genes, 69.m15283 and 56.m02370. The phytase activity of the GMP2 isolated from the culture filtrate was shown as described in Materials and Methods by the release of phosphate from phytic acid. The enzymatic activity was not further analyzed since this activity has been extensively studied previously (6, 21, 38) . Using phytic acid as a substrate, the batch of enzyme analyzed had a specific activity of 100 Ϯ 50 pmol/min/g. Antigenicity of the GMPs. The two GMPs were recognized in Western blot assays by sera from patients with aspergilloma. After N-deglycosylation, they were no longer labeled with patient antibodies, indicating that the immunogenic moiety of these GMPs was the N-glycan whereas the peptide moiety of these two glycoproteins was not antigenic (Fig. 5A) . ELISA data showed that the GMPs were differentially recognized by patient and control sera (P Ͻ 0.01 for both antigens and a df of 23) (Fig. 5B) . In addition, a significant linear fit was seen between the OD values obtained with the different antigens and GM in ELISA (data not shown); this result confirmed the exclusive antigenicity of the N-glycans of the phytase and phospholipase molecules.
DISCUSSION
Galf-containing molecules have been repeatedly shown to be important antigens among human fungal pathogens. This is true for Aspergillus species but also in P. brasiliensis (2) , Sporothrix schenckii, and dermatophytes (17, 33) . The major exocellular antigens of P. brasiliensis used to detect the presence of antibodies in patients with paracoccidioidomycosis is a 43-kDa glycoprotein which contains an N-linked oligosaccharide terminated by a ␤-D-galactofuranosyl residue 136 linked to the mannosyl residues. However, in contrast to A. fumigatus GMPs, the antigenicity of gp43 was due to the peptide moiety rather than to the Galf-containing N-glycan.
Galf is not present in the human host, and galactofuran determinants could play a role in the host immune reactions during Aspergillus infections. Antibodies directed against the galactofuran moiety of the GM have already been identified in immunocompetent patients infected with A. fumigatus (15; J. Sarfati et al., unpublished data). In addition, molecules bearing Galf could help the host to recognize the fungus as non-self and induce cytokine synthesis to activate cellular immunity. This issue has not been investigated yet. Molecules recognized (32, 36, 37) . (ii) When present, Galf is at the nonreducing terminal position.
(iv) N-glycan with or without Galf has also been shown to be present simultaneously on the same glycoprotein. Galactose residues found at the nonreducing end of N-glycans can serve as a stop signal for further mannose addition, similar to the role proposed for ␣-1,3 mannose in S. cerevisiae (8) .
The structure of the N-glycan of the PLC of A. fumigatus looked similar to the N-glycan of ␣-galactosidase A from A. niger. The mannan oligosaccharides of the N-glycan of the ␣-galactosidase of A. niger were of a slightly higher molecular weight, with most abundant components being Hex 10-15 HexNAc 2 whereas they were Hex [6] [7] [8] 1,171) by the ␣-mannosidase treatment. Other batches contained two Galf units that were in the terminal nonreducing position, as shown by GC-MS analysis (data not shown). These variations could be due to the action of a galactofuranosidase that could trim the terminal reducing galactose of the exocellular proteins. Exogalactofuranosidases were shown to be secreted by various Aspergillus species (23, 36) . Studies with both A. niger and A. fumigatus have shown that N-glycans from these two species shared a common essential features: Galf is present as single residues linked to C-2 of the nonreducing terminal mannose residues of N-glycan. The structure of the Galf-containing N-glycans of A. fumigatus is shown in Fig. 6 .
The recognition of N-glycans of these Aspergillus glycoproteins by MAb EB-A2 questioned the previously established identity of the epitope recognized by this MAb. Using chemically synthesized galactofurans of different sizes, we showed that the best-recognized oligosaccharide was a tetra-␤-1,5-galactofuran (30) . The absence of ␤-1,5-galactofuran chains in the N-glycans of Aspergillus GMPs suggests that an oligomannan substituted with a Galf on its terminal nonreducing end can be also recognized by this MAb. Although the Galf-Man epitope from the GMP N-glycan has not been identified yet, our data showed that the linkage between the Galf and the oligomannan is critical: a 1,2 linkage allows IgM binding, whereas a 1,6 linkage, as in gp43 of P. brasiliensis, prevents antigen recognition.
Besides being a main component of members of fungal genera such as Aspergillus and Penicillium, Galf is also present in the cell walls of mycobacteria, in the lipopolysaccharide O antigens of a variety of gram-negative bacteria, and in cell envelope components of eukaryotic parasites. The broad distribution of Galf in critical structures of pathogenic microorganisms and its absence in higher eukaryotes make the biosynthetic pathway of Galf an attractive target for the development of new antimicrobial drugs. The first enzyme involved in this biosynthetic pathway has been well characterized in the genus Mycobacterium. It is a UDP-galactopyranose mutase that converts UDP-galactopyranose to UDP-Galf (25) . This enzyme has not been identified in A. fumigatus, and no homologous sequence was found in the last release of the A. fumigatus TIGR database. The first step of the Galf pathway in A. fumigatus remains unknown, as well as the enzyme(s) responsible for the elongation of the galactofuran side chains or the transferases adding the Galf at the terminal nonreducing end of the mannan of the N-glycan.
A third GMP was isolated from the culture filtrate of A. fumigatus (GMP3) (data not shown). GMP3 was eluted with GMP2 during the first step of purification and further purified on the cation-exchange Mono S column at pH 6.0 at 250 mM NaCl. Although its N-glycan could not be analyzed due to the very small amount of protein purified, this 85-kDa protein was a GMP since de-N-glycosylation abolished the reactivity of GMP3 with the anti-galactofuran MAb. Two internal peptide sequences (FPVLGHQMTHSMD and ALGQLDDTLII VTA) obtained from this protein matched the singleton 59.m08496 of the TIGR database. This protein had high homologies with alkaline phosphatases (62% with alkaline phosphatase of Neurospora crassa). It possessed seven putative sites of N-glycosylation and an N-glycan of 12 kDa (estimated by SDS-PAGE after de-N-glycosylation). The alkaline phosphatase activity was confirmed using p-nitrophenylphosphate as a substrate in a 100 mM Tris-HCl (pH 8.0) buffer (10 ng protein was incubated for 30 min at 37°C with 200 g PNPP, and the assay was stopped by addition of 3 volumes of 6% Na 2 CO 3 ) (data not shown).
The three GMPs of A. fumigatus studied here are secreted enzymes that can be an essential part of a phosphate-scavenging system. For example, the main function of the PLC of A. fumigatus could be to retrieve phosphate from phospholipids. Such a role has been shown for the P. aeruginosa PLC that is regulated at the transcriptional level by Pi. In A. fumigatus, the PLC is also submitted to phosphate repression: it is absent in two defined media containing a high concentration of phosphate (73 mM) and repressed in a Sabouraud medium supplemented with 75 mM phosphate (data not shown). The other two enzymes, alkaline phosphatase and phytase, are directly responsible for phosphate retrieval from the external medium. A. fumigatus growth is highly dependent on free phosphate availability to grow: a concentration of around 1 mM phosphate is found in serum, and A. fumigatus requires 10 times the amount available in human biological fluids for optimal growth (unpublished data). The results presented here and the identification of an acid phosphatase as the major cell wall protein (5) suggest that phosphate availability and scavenging may be a significant determinant of A. fumigatus growth in the host. Strategies to interfere with such pathways could lead to useful therapies.
